Team:UT Dallas/test
From 2011.igem.org
(Difference between revisions)
Line 33: | Line 33: | ||
#menubar.right-menu { width:300px; display:block; float:left; margin-top:-80px; border: none;} | #menubar.right-menu { width:300px; display:block; float:left; margin-top:-80px; border: none;} | ||
.right-menu ul { border: none; width: 300px;} | .right-menu ul { border: none; width: 300px;} | ||
- | #footer-box { background | + | #footer-box { background: none repeat scroll 0 0 transparent;border: medium none;} |
.visualClear { display: none; } | .visualClear { display: none; } | ||
- | #footer { border: none; width: | + | #footer { border: none; width: 960px; margin: 0 auto; padding: 0;} |
.firstHeading { display: none;} | .firstHeading { display: none;} | ||
#f-list a { color: #333; font-size: 10px;} | #f-list a { color: #333; font-size: 10px;} |
Revision as of 21:21, 22 September 2011
Home
Our research area includes structure-function studies of virus, protein, and protein-DNA complexes, and engineering of these molecules for biotechnology applications. We combine the methods of crystallography, biochemistry and molecular modeling to study molecules involved in gene expression controls in cancer cells and virus particles for gene delivery systems. Our aim is to correlate structure to function for the development of therapeutic treatment of disease.